Compare BOKF & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BOKF | ICLR |
|---|---|---|
| Founded | 1910 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 9.3B |
| IPO Year | 2007 | 2001 |
| Metric | BOKF | ICLR |
|---|---|---|
| Price | $130.50 | $116.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 13 |
| Target Price | $133.67 | ★ $178.62 |
| AVG Volume (30 Days) | 221.7K | ★ 1.3M |
| Earning Date | 04-20-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.91% | N/A |
| EPS Growth | ★ 12.65 | N/A |
| EPS | ★ 2.58 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.56 | N/A |
| Revenue Next Year | $5.22 | N/A |
| P/E Ratio | $50.19 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $91.35 | $66.57 |
| 52 Week High | $139.73 | $211.00 |
| Indicator | BOKF | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 49.39 | 50.50 |
| Support Level | $129.49 | $99.11 |
| Resistance Level | $130.52 | $121.03 |
| Average True Range (ATR) | 2.48 | 6.15 |
| MACD | -0.19 | -0.64 |
| Stochastic Oscillator | 46.45 | 32.51 |
BOK Financial Corp is a financial institution based in Oklahoma that offers a broad range of nationally competitive financial products and services. The company operates through three main segments: Commercial Banking, Consumer Banking, and Wealth Management. Commercial Banking provides lending, treasury and cash management, and risk management services, and includes the TransFund EFT network. Consumer Banking focuses on retail lending, deposit services, and mortgage loan origination and servicing. Wealth Management engages mainly in brokerage and trading activities, particularly in U.S. government agency mortgage-backed securities and related derivatives. The company generates the majority of its revenue from the Commercial Banking segment.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.